Abstract
Central nervous system (CNS) infections and inflammatory disease are frequent causes of seizures in the intensive care unit (ICU). Given the high incidence of seizures in these disease states, early recognition and treatment can improve patient outcomes, and should be suspected early in the course of evaluation and treatment. Specific infectious causes of encephalitis such as Herpes Simplex Virus (HSV) and Japanese Encephalitis (JE) can present with seizures in up to 34% and 28% of patients, respectively. An infectious etiology is identified in at least 18% of cases of new onset refractory status epilepticus (NORSE). Additionally, there are frequent electroencephalogram (EEG) findings that are characteristic of certain infections, such as lateralized periodic discharges in HSV infections. In some diseases, such as JE, the EEG can also be used as an additional tool to aid in prognosis. Given that many viral and inflammatory illnesses that affect the CNS have no specific treatment, the management of comorbid seizures may be one of the few targets that can effectively improve outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang K-W et al. The significance of seizures and other predictive factors during the acute illness for the long-term outcome after bacterial meningitis. Seizure. 2005;14:586–92.
Young BG, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology. 1996;47:83–9.
Bleck TP et al. Neurologic complications of critical medical illnesses. Crit Care Med. 1993;21:98–103.
Gans JD, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849–59.
Sutter R, Stevens RD, Kaplan PW. Continuous electroencephalographic monitoring in critically ill patients. Crit Care Med. 2013;41:1124–32.
Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62:1743–8.
Gaspard N et al. New-onset refractory status epilepticus. Neurology. 2015;85:1604–13.
Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62:1743–8.
Claassen J et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356–65.
Claassen J et al. Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care. 2006;4:103–12.
van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354:44–53.
Carrera E et al. Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections. Arch Neurol. 2008;65:1612–8.
Oddo M, Carrera E, Claassen J, Mayer SA, Hirsch LJ. Continuous electroencephalography in the medical intensive care unit. Crit Care Med. 2009;37:2051–6.
Coyle P. Central nervous system infections. Neurol Clin. 1999;17:691–710.
Townsend GC, Scheld WM. Infections of the central nervous system. Adv Intern Med. 1998;43:403–47.
Rotbart HA. Enteroviral infections of the central nervous system. Clin Infect Dis. 1995;20:971–81.
Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988;38:1407–10.
Thigpen MC et al. Bacterial meningitis in the United States, 1998–2007. N Engl J Med. 2011;364:2016–25.
Auburtin M et al. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med. 2006;34:2758–65.
Durand ML et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328:21–8.
Pfister HW, Feiden W, Einhäupl KM. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol. 1993;50:575–81.
Sigurdardóttir B, Björnsson OM, Jónsdóttir KE, Erlendsdóttir H, Gudmundsson S. Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med. 1997;157:425–30.
Hussein AS, Shafran SD. Acute bacterial meningitis in adults. A 12-year review. Medicine (Baltimore). 2000;79:360–8.
Gaieski DF et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010;38:1045–53.
Gaieski DF, Nathan BR, O’Brien NF. Emergency neurologic life support: meningitis and encephalitis. Neurocrit Care. 2015;23(Suppl 2):110–8.
Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;9:CD004405.
DiNubile MJ, Boom WH, Southwick FS. Septic cortical thrombophlebitis. J Infect Dis. 1990;161:1216–20.
Jordan KG. Continuous EEG monitoring in the neuroscience intensive care unit and emergency department. J Clin Neurophysiol. 1999;16:14–39.
Doern GV, Brueggemann A, Holley HP, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:1208–13.
van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis. Lancet (London). 2012;380:1693–702.
Miller S, Mateen FJ, Aksamit AJ. Herpes simplex virus 2 meningitis: a retrospective cohort study. J Neurovirol. 2013;19:166–71.
Barontini F, Ghezzi M, Marconi GP. A case of benign recurrent meningitis of Mollaret. J Neurol. 1981;225:197–206.
Zunt JR, Baldwin KJ. Chronic and subacute meningitis. Continuum (Minneap Minn). 2012;18:1290–318.
Roos KL. Encephalitis. Handb Clin Neurol. 2014;121:1377–81.
Sutter R et al. Electroencephalography for diagnosis and prognosis of acute encephalitis. Clin Neurophysiol. 2015;126:1524–31.
Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia. 2008;49(Suppl 6):13–8.
Michael BD, Solomon T. Seizures and encephalitis: clinical features, management, and potential pathophysiologic mechanisms. Epilepsia. 2012;53(Suppl 4):63–71.
Marks DA, Kim J, Spencer DD, Spencer SS. Characteristics of intractable seizures following meningitis and encephalitis. Neurology. 1992;42:1513–8.
Solomon T, Hart IJ, Beeching NJ. Viral encephalitis: a clinician’s guide. Pract Neurol. 2007;7:288–305.
Michael BD et al. Acute central nervous system infections in adults--a retrospective cohort study in the NHS North West region. QJM. 2010;103:749–58.
Hjalmarsson A, Blomqvist P, Sköldenberg B. Herpes simplex encephalitis in Sweden, 1990–2001: incidence, morbidity, and mortality. Clin Infect Dis. 2007;45:875–80.
McGrath N, Anderson NE, Croxson MC, Powell KF. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry. 1997;63:321–6.
Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antivir Res. 2006;71:141–8.
Lai CW, Gragasin ME. Electroencephalography in herpes simplex encephalitis. J Clin Neurophysiol. 1988;5:87–103.
Smith JB, Westmoreland BF, Reagan TJ, Sandok BA. A distinctive clinical EEG profile in herpes simplex encephalitis. Mayo Clin Proc. 1975;50:469–74.
Jha S, Patel R, Yadav RK, Kumar V. Clinical spectrum, pitfalls in diagnosis and therapeutic implications in herpes simplex encephalitis. J Assoc Physicians India. 2004;52:24–6.
Nahmias AJ, Whitley RJ, Visintine AN, Takei Y, Alford CA. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J. Infect. Dis. 1982;145:829–36.
Boivin G. Diagnosis of herpesvirus infections of the central nervous system. Herpes. 2004;11(Suppl 2):48A–56A.
Singh TD et al. Predictors of outcome in HSV encephalitis. J Neurol. 2015; doi:10.1007/s00415-015-7960-8.
Kennedy PG. A retrospective analysis of forty-six cases of herpes simplex encephalitis seen in Glasgow between 1962 and 1985. Q J Med. 1988;68:533–40.
Prayson R. Neuropathology Review. Neuropathol Rev. 2008; doi:10.1007/978-1-59745-219-9.
Solomon T et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect. 2012;64:347–73.
Whitley RJ, Gnann JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet (London, England). 2002;359:507–13.
Hokkanen L, Salonen O, Launes J. Amnesia in acute herpetic and nonherpetic encephalitis. Arch Neurol. 1996;53:972–8.
Launes J et al. Unilateral hyperfusion in brain-perfusion SPECT predicts poor prognosis in acute encephalitis. Neurology. 1997;48:1347–51.
Arciniegas DB, Anderson CA. Viral encephalitis: neuropsychiatric and neurobehavioral aspects. Curr Psychiatry Rep. 2004;6:372–9.
Hart RP, Kwentus JA, Frazier RB, Hormel TL. Natural history of Klüver-Bucy syndrome after treated herpes encephalitis. South Med J. 1986;79:1376–8.
Sellner J, Trinka E. Seizures and epilepsy in herpes simplex virus encephalitis: current concepts and future directions of pathogenesis and management. J Neurol. 2012;259:2019–30.
Johnson RT et al. Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol. 1985;18:567–73.
Solomon T et al. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain. 2002;125:1084–93.
Solomon T et al. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet (London, England). 1998;351:1094–7.
Misra UK, Kalita J. Anterior horn cells are also involved in Japanese encephalitis. Acta Neurol Scand. 1997;96:114–7.
Patel H, Sander B, Nelder MP. Long-term sequelae of West Nile virus-related illness: a systematic review. Lancet Infect Dis. 2015;15:951–9.
Hollidge BS, González-Scarano F, Soldan SS. Arboviral encephalitides: transmission, emergence, and pathogenesis. J NeuroImmune Pharmacol. 2010;5:428–42.
Zacks MA, Paessler S. Encephalitic alphaviruses. Vet Microbiol. 2010;140:281–6.
Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med. 1997;336:1867–74.
Gould EA, Solomon T. Pathogenic flaviviruses. Lancet (London, England). 2008;371:500–9.
Kramer AH. Viral encephalitis in the ICU. Crit Care Clin. 2013;29:621–49.
Gandelman-Marton R et al. Electroencephalography findings in adult patients with West Nile virus-associated meningitis and meningoencephalitis. Clin Infect Dis. 2003;37:1573–8.
Babi M-A, Raleigh T, Shapiro RE, McSherry J, Applebee A. MRI and encephalography in fatal eastern equine encephalitis. Neurology. 2014;83:1483.
Hall HI et al. Prevalence of diagnosed and undiagnosed HIV infection–United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2015;64:657–62.
Kellinghaus C et al. Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure. 2008;17:27–33.
Dore GJ, Law MG, Brew BJ. Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection. J Neuro AIDS. 1996;1:59–69.
Wong MC, Suite ND, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol. 1990;47:640–2.
Lee KC, Garcia PA, Alldredge BK. Clinical features of status epilepticus in patients with HIV infection. Neurology. 2005;65:314–6.
Miskin DP, Herman ST, Ngo LH, Koralnik IJ. Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy. J. Neurovirol. 2015; doi:10.1007/s13365-015-0414-3.
Holtzman DM, Kaku DA, So YT. New-onset seizures associated with human immunodeficiency virus infection: causation and clinical features in 100 cases. Am J Med. 1989;87:173–7.
Garg RK. HIV infection and seizures. Postgrad Med J. 1999;75:387–90.
Barry M, Gibbons S, Back D, Mulcahy F. Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations. Clin Pharmacokinet. 1997;32:194–209.
Hugen PW et al. Carbamazepine--indinavir interaction causes antiretroviral therapy failure. Ann Pharmacother. 2000;34:465–70.
Toler SM, Wilkerson MA, Porter WH, Smith AJ, Chandler MH. Severe phenytoin intoxication as a result of altered protein binding in AIDS. DICP. 24:698–700.
Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. J Gen Virol. 1996;77(Pt 9):1993–9.
Maggi JD, Halman MH. The effect of divalproex sodium on viral load: a retrospective review of HIV-positive patients with manic syndromes. Can J Psychiatr. 2001;46:359–62.
Pesola GR, Westfal RE. New-onset generalized seizures in patients with AIDS presenting to an emergency department. Acad Emerg Med. 1998;5:905–11.
Brouwer MC, Coutinho JM, van de Beek D. Clinical characteristics and outcome of brain abscess: systematic review and meta-analysis. Neurology. 2014;82:806–13.
Brouwer MC, Tunkel AR, McKhann GM, van de Beek D. Brain abscess. N Engl J Med. 2014;371:447–56.
Legg NJ, Gupta PC, Scott DF. Epilepsy following cerebral abscess. A clinical and EEG study of 70 patients. Brain. 1973;96:259–68.
Chuang M-J et al. Predictors and long-term outcome of seizures after bacterial brain abscess. J Neurol Neurosurg Psychiatry. 2010;81:913–7.
Lu C-H, Chang W-N, Lui C-C. Strategies for the management of bacterial brain abscess. J Clin Neurosci. 2006;13:979–85.
Muzumdar D, Jhawar S, Goel A. Brain abscess: an overview. Int J Surg. 2011;9:136–44.
Scheld MW, Marra CM, Whitley RJ. Infections of the central nervous system. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2014.
Tsai Y-D et al. Intracranial suppuration: a clinical comparison of subdural empyemas and epidural abscesses. Surg Neurol. 2003;59:191–6. discussion 196
Smith HP, Hendrick EB. Subdural empyema and epidural abscess in children. J Neurosurg. 1983;58:392–7.
Bok AP, Peter JC. Subdural empyema: burr holes or craniotomy? A retrospective computerized tomography-era analysis of treatment in 90 cases. J Neurosurg. 1993;78:574–8.
Osborn MK, Steinberg JP. Subdural empyema and other suppurative complications of paranasal sinusitis. Lancet Infect Dis. 2007;7:62–7.
Humphreys H, Jenks PJ. Surveillance and management of ventriculitis following neurosurgery. J Hosp Infect. 2015;89:281–6.
Fried HI et al. The insertion and management of external ventricular drains: an evidence-based consensus statement: a statement for healthcare professionals from the neurocritical care society. Neurocrit Care. 2016;24:61–81.
Ines DF, Markand ON. Epileptic seizures and abnormal electroencephalographic findings in hydrocephalus and their relation to the shunting procedures. Electroencephalogr Clin Neurophysiol. 1977;42:761–8.
Dan NG, Wade MJ. The incidence of epilepsy after ventricular shunting procedures. J Neurosurg. 1986;65:19–21.
Piatt JH, Carlson CV. Hydrocephalus and epilepsy: an actuarial analysis. Neurosurgery. 1996;39:722–7. discussion 727–8
Bourgeois M et al. Epilepsy in children with shunted hydrocephalus. J Neurosurg. 1999;90:274–81.
Ng K, Mabasa VH, Chow I, Ensom MHH. Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults. Neurocrit Care. 2014;20:158–71.
Ferro JM. Vasculitis of the central nervous system. J Neurol. 1998;245:766–76.
Fieschi C, Rasura M, Anzini A, Beccia M. Central nervous system vasculitis. [Review] [76 refs]. J Neurol Sci. 1998;153:159–71.
Hernández-Rodríguez J, Alba MA, Prieto-González S, Cid MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. 48–49:84–9.
Coblyn JS, McCluskey RT. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3–2003. A 36-year-old man with renal failure, hypertension, and neurologic abnormalities. N Engl J Med. 2003;348:333–42.
Moore PM, Fauci AS. Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients. Am J Med. 1981;71:517–24.
Messing RO, Simon RP. Seizures as a manifestation of systemic disease. Neurol Clin. 1986;4:563–84.
Ajmani A, Habte-Gabr E, Zarr M, Jayabalan V, Dandala S. Cerebral blood flow SPECT with Tc-99 m exametamine correlates in AIDS dementia complex stages. A preliminary report. Clin Nucl Med. 1991;16:656–9.
Sehgal M, Swanson JW, DeRemee RA, Colby TV. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc. 1995;70:337–41.
Hanly JG et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Ann Rheum Dis. 2012;71:1502–9.
van Dam AP. Diagnosis and pathogenesis of CNS lupus. Rheumatol Int. 1991;11:1–11.
Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2001;28:766–71.
Karassa FB, Ioannidis JP, Touloumi G, Boki KA, Moutsopoulos HM. Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM. 2000;93:169–74.
Gibson T, Myers AR. Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis. 1975;35:398–406.
Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GR. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum. 1994;37:568–71.
Shrivastava A, Dwivedi S, Aggarwal A, Misra R. Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures. Lupus. 2001;10:45–50.
Liou HH et al. Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons. Life Sci. 1994;54:1119–25.
Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977. Semin Arthritis Rheum. 1979;8:212–21.
West SG. Neuropsychiatric lupus. Rheum Dis Clin N Am. 1994;20:129–58.
Simantov R et al. Antiphospholipid antibodies activate vascular endothelial cells. Lupus. 1996;5:440–1.
Pierangeli SS et al. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation. 1999;99:1997–2002.
Seibold JR, Buckingham RB, Medsger TA, Kelly RH. Cerebrospinal fluid immune complexes in systemic lupus erythematosus involving the central nervous system. Semin Arthritis Rheum. 1982;12:68–76.
Atkins CJ, Kondon JJ, Quismorio FP, Friou GJ. The choroid plexus in systemic lupus erythematosus. Ann Intern Med. 1972;76:65–72.
Winfield JB et al. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med. 1983;74:837–44.
Bluestein HG, Zvaifler NJ. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1976;57:509–16.
Levite M, Ganor Y. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis. Expert Rev Neurother. 2008;8:1141–60.
Cohen SB, Hurd ER. Neurological complications of connective tissue and other ‘collagen-vascular’ diseases. Semin Arthritis Rheum. 1981;11:190–212.
Hanly JG, Walsh NM, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol. 1992;19:732–41.
Primavera A, Audenino D, Mavilio N, Cocito L. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis. 2001;60:534–7.
Bessmertny O, Pham T. Antiepileptic hypersensitivity syndrome: clinicians beware and be aware. Curr Allergy Asthma Rep. 2002;2:34–9.
Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf. 1999;21:489–501.
Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med. 1995;155:2285–90.
Drory VE, Korczyn AD. Hypersensitivity vasculitis and systemic lupus erythematosus induced by anticonvulsants. Clin Neuropharmacol. 1993;16:19–29.
Beck DO, Corbett JJ. Seizures due to central nervous system rheumatoid meningovasculitis. Neurology. 1983;33:1058–61.
Jan JE, Hill RH, Low MD. Cerebral complications in juvenile rheumatoid arthritis. Can Med Assoc J. 1972;107:623–5.
Makela A, Heikki L, Sillanpaa M. Neurological manifestations of rheumatoid arthritis. In: Vinken PJ, Bruyen GW, editors. Handbook of clinical neurology, vol. 38. Amsterdam: Elsevier North Holland; 1979. p. 479–503.
Mandybur TI. Cerebral amyloid angiopathy: possible relationship to rheumatoid vasculitis. Neurology. 1979;29:1336–40.
Neamtu L et al. Rheumatoid disease of the CNS with meningeal vasculitis presenting with a seizure. Neurology. 2001;56:814–5.
Hietaharju A, Jääskeläinen S, Hietarinta M, Frey H. Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluation. Acta Neurol Scand. 1993;87:382–7.
Estey E, Lieberman A, Pinto R, Meltzer M, Ransohoff J. Cerebral arteritis in scleroderma. Stroke. 10:595–7.
Alexander E. Central nervous system disease in Sjögren’s syndrome. New insights into immunopathogenesis. Rheum Dis Clin N Am. 1992;18:637–72.
Spezialetti R, Bluestein HG, Peter JB, Alexander EL. Neuropsychiatric disease in Sjögren’s syndrome: anti-ribosomal P and anti-neuronal antibodies. Am J Med. 1993;95:153–60.
Bennett RM, Bong DM, Spargo BH. Neuropsychiatric problems in mixed connective tissue disease. Am J Med. 1978;65:955–62.
Akhan G, Andermann F, Gotman MJ. Ulcerative colitis, status epilepticus and intractable temporal seizures. Epileptic Disord. 2002;4:135–7.
Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain. 1999;122(Pt 1):2171–82.
Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet's Disease. Lancet (London, England). 1990;335:1078–80.
Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications in Behçet’s syndrome. Brain. 1999;122(Pt 1):2183–94.
Aykutlu E, Baykan B, Serdaroglu P, Gökyigit A, Akman-Demir G. Epileptic seizures in Behçet disease. Epilepsia. 2002;43:832–5.
Durán E, Chacón JR. Behçet’s disease with atypical double neurological involvement. Rev Neurol. 33:333–4.
O’Duffy JD et al. Interferon-alpha treatment of Behçet’s disease. J Rheumatol. 1998;25:1938–44.
Vignola S et al. Brain perfusion spect in juvenile neuro-Behçet’s disease. J Nucl Med. 2001;42:1151–7.
Mead S, Kidd D, Good C, Plant G. Behçet’s syndrome may present with partial seizures. J Neurol Neurosurg Psychiatry. 2000;68:392–3.
Krumholz A, Stern BJ. Neurologic manifestations of sarcoidosis. Handb Clin Neurol. 2014;119:305–33.
Valeyre D, Chapelon-Abric C, Belin C, Dumas JL. Sarcoidosis of the central nervous system. La Rev médecine interne/fondée … par la Société Natl Fr médecine interne. 1998;19:409–14.
Joseph FG, Scolding NJ. Sarcoidosis of the nervous system. Pract Neurol. 2007;7:234–44.
Varelas PN. How I treat status epilepticus in the Neuro-ICU. Neurocrit Care. 2008;9:153–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Schomer, A.C., Ziai, W., Rehman, M., Nathan, B.R. (2017). Infection or Inflammation and Critical Care Seizures. In: Varelas, P., Claassen, J. (eds) Seizures in Critical Care. Current Clinical Neurology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-49557-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-49557-6_17
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-49555-2
Online ISBN: 978-3-319-49557-6
eBook Packages: MedicineMedicine (R0)